BindingDB logo
myBDB logout

4 articles for thisTarget


The following articles (labelled with PubMed ID or TBD) are for your review
PMIDDataArticle TitleOrganization
23600925 12 Development of highly potent and selective diaminothiazole inhibitors of cyclin-dependent kinases.EBI H. Lee Moffitt Cancer Center and Research Institute
29370702 41 Discovery and Preclinical Development of IIIM-290, an Orally Active Potent Cyclin-Dependent Kinase Inhibitor.EBI Csir-Indian Institute of Integrative Medicine